A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.
Clinical trial NCT02612779 · COMPLETED
Trial details
- NCT number
- NCT02612779
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-09
- Primary completion
- 2019-07-29
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.